Biomarker-based Bayesian randomized clinical trial design for identifying a target population

DOI10.1002/SIM.9749zbMATH Open1545.62578MaRDI QIDQ6625817

Akiyoshi Nakakura, Satoshi Morita, Yasuo Sugitani, H. Yamamoto

Publication date: 28 October 2024

Published in: Statistics in Medicine (Search for Journal in Brave)

zbMATH Keywords

randomized clinical trialbiomarkerinterim analysistime-to-event outcomeBayesian study design

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• A Bayesian justification of Cox's partial likelihood
• A semiparametric Bayesian approach to population finding with time‐to‐event and toxicity data in a randomized clinical trial

This page was built for publication: Biomarker-based Bayesian randomized clinical trial design for identifying a target population

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6625817)